Streetbeat News

Stock Prices

CBAY

GILD

Gilead Sciences Inc (NASDAQ:GILD) is set to acquire CymaBay Therapeutics Inc (NASDAQ:CBAY) for $4.3 billion, or $32.50 per share in cash. This acquisition aims to enhance Gilead's liver portfolio with CymaBay's lead product candidate, seladelpar, for primary biliary cholangitis. Meanwhile, the Dow Jones index rose by 0.48%, and the NASDAQ and S&P 500 also saw gains. Energy shares led the market with a 1.1% increase, while health care shares slightly declined.

Portfolio Pulse from Avi Kapoor

February 12, 2024 | 5:30 pm

PPL

PPL Corporation's (NYSE:PPL) short interest has decreased by 12.23% since the last report, with 15.73 million shares sold short, representing 2.44% of its float. It would take about 3.27 days to cover all short positions. This decline in short interest could indicate a more bullish sentiment towards PPL compared to its peers, where the average short interest as a percentage of float is 2.39%.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 5:30 pm

DE

Deere (NYSE:DE) has delivered an average annual return of 19.54% over the past 5 years, outperforming the market by 6.89% annually. With a current market capitalization of $107.10 billion, an initial investment of $1000 in DE 5 years ago would be worth $2,389.85 today.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 5:30 pm

PATK

Patrick Industries (NYSE:PATK) has seen an 8.96% increase in short percent of float since its last report, with 1.04 million shares sold short, representing 5.96% of available shares. This indicates a bearish market sentiment, although it has less short interest compared to its peers' average of 8.19%. The article suggests that an increase in short interest can sometimes be bullish for a stock.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 5:30 pm

BSX

Over the past 10 years, Boston Scientific (NYSE:BSX) has outperformed the market with an annualized return of 17.13%, turning a $1000 investment into $4,859.87 today. The company's market capitalization stands at $95.60 billion.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 5:30 pm

ETR

Entergy's (NYSE:ETR) short interest has increased by 3.06% since the last report, with 1.87 million shares sold short, representing 1.01% of its float. This indicates a bearish market sentiment towards ETR, although it has less short interest compared to its peers' average of 2.46%. The rise in short interest does not necessarily predict a near-term price fall but suggests increased bearishness among traders.

Portfolio Pulse from Benzinga Insights

February 12, 2024 | 5:30 pm

ADM

On CNBC, Steve Weiss announced he has sold most of his holdings in Archer-Daniels-Midland (ADM), a major player in the agricultural and food processing industry.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 5:30 pm

CVNA

Carvana (CVNA) sees significant options activity with a sweep of 1000 Mar 1 $80 calls at $0.93 each, ahead of its earnings report on February 22. This activity suggests investor anticipation of positive news.

Portfolio Pulse from Charles Gross

February 12, 2024 | 5:25 pm

RNLX

Renalytix shares experienced a significant surge, leading to a trading halt due to a circuit breaker trigger. The stock is currently up by 527.1%.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 5:23 pm

NA

Trading of Nano Labs shares has resumed after a temporary halt.

Portfolio Pulse from Benzinga Newsdesk

February 12, 2024 | 5:22 pm